| Jingyang Feng, MD | |
|
1901 W Harrison St, Department Of Pathology, Building 110, Room 2209, Chicago, IL 60612-3714 | |
| (312) 864-7554 | |
| Not Available |
| Full Name | Jingyang Feng |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 29 Years |
| Location | 1901 W Harrison St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285860817 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| John H Stroger Jr Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cook County | 2860398088 | 619 |
News Archive
Chemokine Therapeutics has announced that it has been granted U.S. Patent No. 6,875,738 relating to the use of its anti-cancer compound, CTCE-9908, in the treatment of cancer and inhibition of angiogenesis. CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been included on a list of preliminary additions to the Russell 3000® Index, the Russell Microcap® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com.
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2012.
› Verified 8 days ago
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
Chemokine Therapeutics has announced that it has been granted U.S. Patent No. 6,875,738 relating to the use of its anti-cancer compound, CTCE-9908, in the treatment of cancer and inhibition of angiogenesis. CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been included on a list of preliminary additions to the Russell 3000® Index, the Russell Microcap® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com.
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2012.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jingyang Feng, MD 1901 W Harrison St, Department Of Pathology, Building 110, Room 2209, Chicago, IL 60612-3714 Ph: (312) 864-7554 | Jingyang Feng, MD 1901 W Harrison St, Department Of Pathology, Building 110, Room 2209, Chicago, IL 60612-3714 Ph: (312) 864-7554 |
News Archive
Chemokine Therapeutics has announced that it has been granted U.S. Patent No. 6,875,738 relating to the use of its anti-cancer compound, CTCE-9908, in the treatment of cancer and inhibition of angiogenesis. CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been included on a list of preliminary additions to the Russell 3000® Index, the Russell Microcap® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com.
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2012.
› Verified 8 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Katrina Krogh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611 Phone: 312-926-7913 Fax: 312-926-3127 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |